Beam Therapeutics (BEAM) Change in Acquisitions & Divestments (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Change in Acquisitions & Divestments for 7 consecutive years, with -$378.1 million as the latest value for Q3 2025.

  • Quarterly Change in Acquisitions & Divestments fell 2.7% to -$378.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $5.7 million for FY2025, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q3 2025 was -$378.1 million at Beam Therapeutics, down from $166.7 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $365.5 million in Q2 2023, with the low at -$378.1 million in Q3 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $157.2 million, with a median of $191.9 million recorded in 2025.
  • The sharpest move saw Change in Acquisitions & Divestments surged 683.91% in 2022, then tumbled 235.63% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $106.4 million in 2021, then surged by 238.59% to $360.1 million in 2022, then tumbled by 56.97% to $155.0 million in 2023, then tumbled by 337.57% to -$368.1 million in 2024, then fell by 2.7% to -$378.1 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at -$378.1 million, $166.7 million, and $217.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.